title: A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers.
abstract: Approximately 40% of males with the fragile X premutation develop fragile X-associated tremor/ataxia syndrome after age 50. Although the thalamus and basal ganglia play a crucial role in movement disorders, their involvement in fragile X premutation carriers has not been systematically investigated. The current study characterized structural abnormalities associated with fragile X premutation carriers (with and without fragile X-associated tremor/ataxia syndrome) in the thalamus, caudate nucleus, putamen, and globus pallidus using T1-weighted and diffusion tensor imaging. Male premutation carriers with fragile X-associated tremor/ataxia syndrome showed significant volume atrophy and diffusion-weighted signal loss in all 4 structures compared with the control group. They also exhibited volume atrophy and diffusion-weighted signal loss in the thalamus and striatum compared with the premutation carriers without fragile X-associated tremor/ataxia syndrome. Importantly, many of the measurements exhibited robust correlations with symptom severity, with volume and diffusion-weighted imaging measurements displaying negative correlations and fractional anisotropy measurements displaying positive correlations. The current study demonstrated involvement of all 4 subcortical gray matter structures in fragile X-associated tremor/ataxia syndrome, with significant volume atrophy, and possible iron deposition indicated by the diffusion-weighted signal loss. The significant correlation between the subcortical measurements and symptom severity suggests the benefits of tracking structural changes in subcortical gray matter in future longitudinal studies for early detection and disease monitoring. © 2013 Movement Disorder Society.
authors: University of California-Davis, Davis, CA, USA.
authors: Jun Yi
authors: JY
authors: Wang
authors: Randi J
authors: RJ
authors: Hagerman
authors: Susan M
authors: SM
authors: Rivera
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001284:Atrophy; D001921:Brain / Q000473:pathology*; D056324:Diffusion Tensor Imaging; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics; D005600:Fragile X Syndrome / Q000235:genetics / Q000473:pathology*; D007839:Functional Laterality; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging; D016017:Odds Ratio
chemical_list: D051860:Fragile X Messenger Ribonucleoprotein 1
keywords: diffusion tensor imaging; diffusion-weighted imaging; genetic disorder; iron dysregulation; neurodegeneration
references: Radiology. 2010 Nov;257(2):455-62
references: 20843991
references: Arch Neurol. 2008 Apr;65(4):495-8
references: 18413472
references: Arch Neurol. 2012 Apr;69(4):482-9
references: 22491193
references: Nat Neurosci. 2003 Jul;6(7):750-7
references: 12808459
references: Biochem J. 2010 Aug 1;429(3):545-52
references: 20513237
references: Brain. 2011 Mar;134(Pt 3):863-78
references: 21354978
references: J Magn Reson B. 1996 Jun;111(3):209-19
references: 8661285
references: Neuroimage. 2002 Sep;17(1):479-89
references: 12482100
references: Neurobiol Dis. 2012 Apr;46(1):1-18
references: 22266337
references: Brain. 2006 Jan;129(Pt 1):243-55
references: 16332642
references: J Clin Exp Neuropsychol. 2008 Nov;30(8):853-69
references: 18608667
references: Mov Disord. 2011 Aug 1;26(9):1627-32
references: 21618607
references: Clin Chem. 2010 Mar;56(3):399-408
references: 20056738
references: Brain Res Bull. 2009 Feb 16;78(2-3):69-74
references: 18950692
references: Neurogenetics. 2011 May;12(2):123-35
references: 21279400
references: Neuroimage. 2012 Feb 1;59(3):2625-35
references: 21925274
references: Am J Hum Genet. 2000 Jan;66(1):6-15
references: 10631132
references: Brain Cogn. 2005 Feb;57(1):53-60
references: 15629215
references: Neurobiol Aging. 2010 Mar;31(3):482-93
references: 18513834
references: Acta Neuropathol. 2011 Oct;122(4):467-79
references: 21785977
references: Mov Disord. 2011 Jun;26(7):1329-36
references: 21484870
references: Brain. 2002 Aug;125(Pt 8):1760-71
references: 12135967
references: JAMA. 2004 Jan 28;291(4):460-9
references: 14747503
references: Neurology. 2001 Jul 10;57(1):127-30
references: 11445641
references: Magn Reson Med. 1993 Apr;29(4):459-64
references: 8464361
references: Hum Mol Genet. 2011 Aug 1;20(15):3079-92
references: 21558427
references: J Magn Reson B. 1994 Mar;103(3):247-54
references: 8019776
references: Genet Med. 2011 May;13(5):392-9
references: 21270637
references: Magn Reson Med. 2004 Sep;52(3):612-8
references: 15334582
references: Neuroimage. 2004;23 Suppl 1:S208-19
references: 15501092
references: J Magn Reson Imaging. 1993 Nov-Dec;3(6):863-8
references: 8280975
references: Am J Hum Genet. 2001 Aug;69(2):351-60
references: 11443541
references: Neuroimage. 2011 Jun 1;56(3):907-22
references: 21352927
references: J Neurochem. 1958 Oct;3(1):41-51
references: 13611557
references: J Clin Psychiatry. 2011 Feb;72(2):175-82
references: 20816038
references: Ann Neurol. 2004 Apr;55(4):522-9
references: 15048891
references: Hum Mol Genet. 2002 Feb 15;11(4):371-8
references: 11854169
references: Pediatr Neurol. 2001 Aug;25(2):118-29
references: 11551742
references: Am J Hum Genet. 2003 Apr;72(4):869-78
references: 12638084
references: Arch Neurol. 1992 Jul;49(7):711-7
references: 1497497
references: AJNR Am J Neuroradiol. 1990 May;11(3):423-9
references: 2161612
references: Magn Reson Imaging. 2005 Jan;23(1):1-25
references: 15733784
references: Psychol Rev. 2010 Apr;117(2):541-74
references: 20438237
references: Curr Biol. 2000 Jul 13;10(14):R509-11
references: 10899013
references: Cereb Cortex. 2005 Jan;15(1):31-9
references: 15238447
references: Cell. 1991 May 31;65(5):905-14
references: 1710175
references: J Mol Diagn. 2009 Jul;11(4):324-9
references: 19460941
references: Results Probl Cell Differ. 2012;54:337-57
references: 22009361